...
首页> 外文期刊>Cancer epidemiology >Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China
【24h】

Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China

机译:中国江苏省结直肠癌患者后外科生存率的临床病理和流行病学特征

获取原文
获取原文并翻译 | 示例
           

摘要

Poor survival among colorectal cancer (CRC) patients has been widely associated with clinico-epidemiological features and treatment regimen. In Jiangsu (China), however, it is not known which one of the prognostic factors explains the survival disparities among patients with CRC. This prospective study using 1078 patients (stages I-IV) that underwent surgery at Jiangsu Hospital, explored the relevant factors affecting the prognoses of right-side colon cancer (RCC), left-side colon cancer (LCC) and rectal cancer (ReC) patients. Of these cases, 234 (21.7%), 241 (22.4%) and 603 (55.9%) were found to have RCC, LCC and ReC respectively. Compared to LCC, RCC exhibited a greater proportion of older patients, poorly differentiated carcinomas, higher T-stage and higher TNM-stage. The overall survival (OS) for RCC was 60 vs.78 or 77 months for LCC or ReC respectively (P = 0.030). There were no significant differences in OS between LCC and ReC across the subgroups (P = 0.633). In multivariate analysis, RCC patients had age ( > 60 vs. 60 vs. <= 60 years, HR = 2.199, P < 0.0001), alcohol consumption (drinker vs. nondrinker, HR = 0.510, P = 0.034), tumor grade (Poor vs. well/moderate, HR = 2.759, P = 0.031) and T-stage (T3-4 vs. T1-2, HR = 1.742, P < 0.0001) were found to be predictors of mortality for ReC. There were significant pairwise interactions across subgroups. Furthermore, significant differences were observed for LCC vs. RCC (OS, HR = 0.783, P = 0.039), but no statistically significant differences for ReC vs. RCC (P = 0.149) and LCC vs. ReC (P = 0.355). Nevertheless, significant differences remained between ReC vs. RCC for male (HR = 0.591, P = 0.009), drinker (HR = 0.396, P = 0.005), rural resident (HR = 0.437,P = 0.022), tumor grade (well/moderate, HR = 0.475, P = 0.022), T-stage (T1-2, HR = 0.362, P = 0.001), N-stage (N0, HR = 0.604, P = 0.011), M-stage(M0, HR = 0.401, P = 0.006) and TNM-stage (I-II, HR = 0.567, P = 0.005). Statistically significant differences were observed for LCC vs. RCC for gender (female, HR = 0.495, P = 0.003) and T-stage (T1-2, HR = 0.417, P = 0.010) as well as for LCC vs. ReC in patients with smoking habits (HR = 1.951, P = 0.002) and M-stage (M0, HR = 2.291, P = 0.003). These findings suggest that the variations in CRC post-surgical survival in China may be primarily explained with the clinicopathologic features and epidemiological characteristic of the patients. Patients with RCC had significantly worse OS compared to both LCC and ReC in several subgroups.
机译:结直肠癌(CRC)患者的存活率不佳已与临床流行病学特征和治疗方案的患者广泛相关。然而,在江苏(中国),尚不清楚哪一种预后因素解释了CRC患者的生存差异。这种前瞻性研究使用1078名患者(阶段I-IV)在江苏医院进行手术,探讨了影响右侧结肠癌(RCC),左侧结肠癌(LCC)和直肠癌(REC)的相关因素耐心。在这些情况下,发现234(21.7%),241(22.4%)和603(55.9%)分别具有RCC,LCC和REC。与LCC相比,RCC表现出更大比例的老年患者,分化差,癌差,较高的T-阶段和更高的TNM-阶段。 RCC的总存活(OS)分别为LCC或REC的60 vs.78或77个月(P = 0.030)。 LCC和跨子组之间的OS没有显着差异(P = 0.633)。在多变量分析中,RCC患者的年龄(> 60 vs.60 vs. <= 60岁,HR = 2.199,P <0.0001),酒精消费(饮酒者与非产品,HR = 0.510,P = 0.034),肿瘤等级(差与井/中度,HR = 2.759,p = 0.031)和T-阶段(T3-4 vs.T1-2,HR = 1.742,P <0.0001)是REC的死亡率的预测因素。亚组中存在显着的成对相互作用。此外,对于LCC与RCC(OS,HR = 0.783,P = 0.039)观察到显着差异,但对RC与RCC(P = 0.149)和LCC与RC(P = 0.355)没有统计学上显着的差异。尽管如此,官方(HR = 0.591,P = 0.009),饮用者(HR = 0.396,P = 0.005),农村居民(HR = 0.437,P = 0.022),肿瘤等级(HR = 0.437,P = 0.022),肿瘤等级(井/中等,HR = 0.475,P = 0.022),T-阶段(T1-2,HR = 0.362,P = 0.001),N-阶段(N0,HR = 0.604,P = 0.011),M阶段(M0,HR = 0.401,p = 0.006)和TNM-阶段(I-II,HR = 0.567,P = 0.005)。对于性别的LCC与RCC进行统计学显着的差异(雌性,HR = 0.495,P = 0.003)和T-阶段(T1-2,HR = 0.417,P = 0.010)以及LCC与患者的RCC与RC吸烟习惯(HR = 1.951,P = 0.002)和M-阶段(M0,HR = 2.291,P = 0.003)。这些研究结果表明,中国手术后生存率的变异可以主要针对患者的临床病理特征和流行病学特征来解释。与几个亚组中的LCC和REC相比,RCC患者显着差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号